What Are Costs, Consequences Associated with Misdiagnosed Cellulitis?


Media Advisory: To contact corresponding study author Arash Mostaghimi, M.D., M.P.A., M.P.H., call Johanna Younghans at 617-525-6373 or email JYOUNGHANS@partners.org.

Related material: The editorial, “Dermatologists Must Take an Active Role in the Diagnosis of Cellulitis,” by Sotonye Imadojemu, M.D., M.B.E., and Misha Rosenbach, M.D., of the University of Pennsylvania, Philadelphia, also is available.

To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2016.3816


JAMA Dermatology

Cellulitis is a common bacterial skin infection and a new study published online by JAMA Dermatology suggests misdiagnosis of the condition is associated with unnecessary hospitalizations and antibiotic use, as well as avoidable health care spending.

Cellulitis leads to about 2.3 million emergency department visits annually in the United States and between 14 percent and 17 percent of those patients are admitted to the hospital. However, many inflammatory conditions of the skin mimic cellulitis and are known as “pseudocellulitis.”

Arash Mostaghimi, M.D., M.P.A., M.P.H., of the Brigham and Women’s Hospital and Harvard Medical School, Boston, and coauthors examined the costs and consequences of misdiagnosed cellulitis. The authors examined data for patients admitted from the emergency department of a large urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012. Patients were considered to have “pseudocellulitis” if they were given an alternative diagnosis during their hospital stay, on discharge or within 30 days of discharge.

The study included 259 patients, of whom 79 (30.5 percent) were misdiagnosed with cellulitis, and 52 of the misdiagnosed patients had been admitted primarily for the treatment of cellulitis. Among the 52 misdiagnosed patients, the average length of their hospital stay was nearly five days and 25 percent stayed longer than a week. A clinical review suggests that 44 of the 52 patients with misdiagnosed cellulitis would not have required hospital admission if they had been diagnosed correctly. Additionally, 48 (92 percent) of the 52 misdiagnosed patients would not have required any antibiotics based on their ultimate diagnoses, according to the report.

The authors estimate that misdiagnosed cellulitis leads to between 50,000 and 130,000 unnecessary hospitalizations and $195 million to $515 million in avoidable health care spending, not accounting for the costs of antibiotics and other complications that may result from unnecessary treatment. Unnecessary antibiotics and hospitalizations for misdiagnosed cellulitis also were projected to cause other serious infections, including Clostridium difficile, according to the article.

Study limitations include the generalizability of the findings because the investigation was conducted at a single institution. The authors used conservative estimates to present the range of costs and therefore may have underestimated the true cost of misdiagnosis.

“Our study serves as a call to arms for improving the care of patients with suspected lower extremity cellulitis. A combination of systems improvement and further categorization of the biology of cellulitis may lead to a combination of clinical findings and biomarkers that will reduce incorrect diagnosis,” the study concludes.

(JAMA Dermatology. Published online November 2, 2016. doi:10.1001/jamadermatol.2016.3816. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor’s Note:  Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.


#  #  #


For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.